What is a stock summary page? Click here for an overview.
Business Description
Mytrex Health Technologies Inc
NAICS : 332911
SIC : 3491
ISIN : TW0004431002
Description
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.23 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 13.09 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.36 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 81.9 | |||||
| 3-Year EBITDA Growth Rate | -23.5 | |||||
| 3-Year EPS without NRI Growth Rate | -80.5 | |||||
| 3-Year Book Growth Rate | -10.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.23 | |||||
| 9-Day RSI | 26.17 | |||||
| 14-Day RSI | 33.8 | |||||
| 3-1 Month Momentum % | 27.18 | |||||
| 6-1 Month Momentum % | 16.71 | |||||
| 12-1 Month Momentum % | -11.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.71 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 48.84 | |||||
| Days Sales Outstanding | 31.52 | |||||
| Days Payable | 50.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 12.44 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.6 | |||||
| Operating Margin % | -4.37 | |||||
| Net Margin % | -4.68 | |||||
| FCF Margin % | 0.94 | |||||
| ROE % | -12.75 | |||||
| ROA % | -6.62 | |||||
| ROIC % | -11.22 | |||||
| 3-Year ROIIC % | -37.09 | |||||
| ROC (Joel Greenblatt) % | -29.67 | |||||
| ROCE % | -10.01 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 22.5 | |||||
| PS Ratio | 0.45 | |||||
| PB Ratio | 1.31 | |||||
| Price-to-Tangible-Book | 1.52 | |||||
| Price-to-Free-Cash-Flow | 47.03 | |||||
| Price-to-Operating-Cash-Flow | 24.71 | |||||
| EV-to-EBIT | -9.49 | |||||
| EV-to-EBITDA | 42.88 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | 46.07 | |||||
| Price-to-GF-Value | 0.54 | |||||
| Price-to-Projected-FCF | 0.76 | |||||
| Price-to-Median-PS-Value | 0.37 | |||||
| Price-to-Net-Current-Asset-Value | 5.38 | |||||
| Earnings Yield (Greenblatt) % | -10.53 | |||||
| FCF Yield % | 2.11 | |||||
| Forward Rate of Return (Yacktman) % | -18.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mytrex Health Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,758.684 | ||
| EPS (TTM) (NT$) | -2.253 | ||
| Beta | 0.84 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 35.63 | ||
| 14-Day RSI | 33.8 | ||
| 14-Day ATR (NT$) | 0.842373 | ||
| 20-Day SMA (NT$) | 23.2575 | ||
| 12-1 Month Momentum % | -11.74 | ||
| 52-Week Range (NT$) | 19.5 - 32.5 | ||
| Shares Outstanding (Mil) | 36.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mytrex Health Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mytrex Health Technologies Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mytrex Health Technologies Inc Frequently Asked Questions
What is Mytrex Health Technologies Inc(ROCO:4431)'s stock price today?
The current price of ROCO:4431 is NT$21.45. The 52 week high of ROCO:4431 is NT$32.50 and 52 week low is NT$19.50.
When is next earnings date of Mytrex Health Technologies Inc(ROCO:4431)?
The next earnings date of Mytrex Health Technologies Inc(ROCO:4431) is .
Does Mytrex Health Technologies Inc(ROCO:4431) pay dividends? If so, how much?
Mytrex Health Technologies Inc(ROCO:4431) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers